Geron Corp (GERN)
3.58
+0.08
(+2.29%)
USD |
NASDAQ |
Apr 24, 16:00
3.55
-0.03
(-0.84%)
After-Hours: 20:00
Geron Cash from Financing (Quarterly): 33.28M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.28M |
| September 30, 2023 | 29.35M |
| June 30, 2023 | 18.34M |
| March 31, 2023 | 281.05M |
| December 31, 2022 | 11.92M |
| September 30, 2022 | 4.778M |
| June 30, 2022 | 70.56M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 19.64M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 12.65M |
| March 31, 2021 | 16.26M |
| December 31, 2020 | -0.581M |
| September 30, 2020 | 23.98M |
| June 30, 2020 | 144.26M |
| March 31, 2020 | 0.686M |
| December 31, 2019 | 10.27M |
| September 30, 2019 | 8.984M |
| June 30, 2019 | 0.243M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.008M |
| September 30, 2018 | 9.087M |
| June 30, 2018 | 82.32M |
| March 31, 2018 | 1.553M |
| December 31, 2017 | 1.074M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.037M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.012M |
| September 30, 2016 | 0.09M |
| June 30, 2016 | 0.241M |
| March 31, 2016 | 0.826M |
| December 31, 2015 | 0.81M |
| September 30, 2015 | 0.21M |
| June 30, 2015 | 0.078M |
| March 31, 2015 | 1.477M |
| December 31, 2014 | 0.53M |
| September 30, 2014 | 0.105M |
| June 30, 2014 | 0.105M |
| March 31, 2014 | 97.62M |
| December 31, 2013 | 6.06M |
| September 30, 2013 | 0.433M |
| June 30, 2013 | 0.049M |
| March 31, 2013 | 0.011M |
| December 31, 2012 | 0.07M |
| September 30, 2012 | 0.001M |
| June 30, 2012 | 0.079M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -4.189M |
| September 30, 2011 | 4.287M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.581M
Minimum
Dec 2020
281.05M
Maximum
Mar 2023
36.09M
Average
12.65M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 479.92M |
| SELLAS Life Sciences Group Inc | 3.386M |
| Johnson & Johnson | -4.655B |
| Immuneering Corp | 0.0078M |
| Moderna Inc | -109.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.94M |
| Cash from Investing (Quarterly) | 47.57M |
| Free Cash Flow | -168.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0689 |
| Free Cash Flow to Equity (Quarterly) | -71.05M |
| Free Cash Flow Yield | -8.31% |